20000303
 U.S. Sent Subpoena to Schering-Plough   By By Robert Langreth and David S. Cloud, The Wall Street Journal,  Mar 3, 2000  The exact nature and extent of the government inquiry was unclear. But in a regulatory filing, the Madison, N.J., drug maker revealed that it had received the subpoena from the U.S. attorney's office in Philadelphia as part of an inquiry that appeared to focus on the company's disease-management programs, which are designed to help managed-care plans use the company's drugs to care for certain patients.   
